WASHINGTON, DC — In less than 24 hours, more than 1,600 patients from every state signed a petition supporting H.R. 3, landmark legislation to let Medicare negotiate lower drug prices. Patients For Affordable Drugs Now launched the petition this week as the House announced a vote on The Lower Drug Costs Now Act. The petition comes on the heels of television, radio, and digital advertisements in recent months that illustrate the impact of high prescription drug prices on everyday Americans. In addition, patient advocates from across the country have flown to Washington to meet their members of Congress and thousands more have written letters in support of policies to lower drug prices.
“Americans are being being ripped off, and we know Medicare negotiation is a common sense solution to drive down drug prices,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs Now. “Everyone, everywhere is tired of paying two to three times what other developed nations pay for the exact same prescription drugs. It’s time for the leaders in Washington to put aside differences and give the American public a win to lower drug prices.”
H.R. 3 would:
- Let Medicare negotiate lower drug prices and extend lower prices to all Americans with public or private sector insurance.
- Cap out-of-pocket spending at $2,000 for Medicare beneficiaries. Currently, seniors can pay more than $15,000 a year for a single prescription drug.
- Stop drug company price gouging by requiring corporations to pay Medicare if drug prices increase faster than the rate of inflation.
- Add hearing, dental, and vision coverage for Medicare beneficiaries.
- Support innovation and new drug development by investing savings from Medicare negotiations into the world-class research being done at the NIH.
Currently, nearly 1 in 3 Americans report not taking their medicines as prescribed because of the cost. Lower drug prices will mean better adherence to drugs, which will improve health outcomes and extend life expectancy for millions of Americans. That’s likely why nine of 10 Americans from both political parties agree one of Congress’ top priorities should be to lower drug prices.